Specifications
Product
Strength
Components
Appearance
Purity
Use
Storage
Retatrutide 30 mg
Next-Generation Triple Receptor Peptide
Retatrutide
30 mg
Triple-Agonist
White Lyophilized Peptide
>99%
Research Use Only
Refrigerate 36 - 46F (2 - 8C) after reconstitution
A long-acting investigational peptide studied for its combined GLP-1, GIP, and glucagon receptor activity in metabolic and obesity-related research models.
GLP-1
Studied for appetite regulation and glucose homeostasis.
Mechanism of Action
GIP
Studied for metabolic efficiency and insulin response
Glucagon
Studied for effects on energy expenditure and lipid metabolism.
Research Overview
Retatrutide, a long-acting investigational peptide studied for its combined GLP-1, GIP, and glucagon receptor (triple-agonist) activity in metabolic and obesity-related research models. By simultaneously activating three distinct metabolic receptors, Retatrutide has become a prominent focus of modern metabolic research. Investigators are exploring its effects on appetite signaling, energy balance, glucose regulation, and lipid utilization to better understand its complex biological activity.
As research continues, its multi-receptor design is providing valuable insights into metabolic physiology and next-generation peptide therapeutics.
For laboratory research use only. Not intended for human or veterinary use.